Menu
MENU
Sign In   
Search
HOME    >   Products
auditory comprehension test

FrSBe™

Frontal Systems Behavior Scale

Janet Grace, PhD, and Paul F. Malloy, PhD

Purpose:
Assesses behavior related to frontal systems damage
Format:
Paper and pencil, Online administration and scoring via PARiConnect
Age range:
18 years to 95 years
Time:
10 minutes
Qualification level:
B
B
A degree from an accredited 4-year college or university in psychology, counseling, speech-language pathology, or a closely related field plus satisfactory completion of coursework in test interpretation, psychometrics and measurement theory, educational statistics, or a closely related area; or license or certification from an agency that requires appropriate training and experience in the ethical and competent use of psychological tests. Close

The FrSBe fills a gap in the assessment of frontal systems behavioral syndromes by providing a means to identify and quantify disordered natural behavior so that problems may be targeted for treatment.

Features and benefits

  • Provides a brief, reliable, and valid measure of three frontal systems behavioral syndromes: apathy, disinhibition, and executive dysfunction.
  • Quantifies behavioral changes over time by including both baseline (retrospective) and current assessments of behavior.
  • Includes a total score as well as scores on three subscales that correspond to the three frontal systems behavioral syndromes.

Test structure

  • This 46-item behavior rating scale is much easier and less time-consuming to administer than a neuropsychological test battery.
  • Two hand-scorable, carbonless test booklets (self and family) are available. Items are written at a sixth-grade reading level. Two profile forms (self and family) allow comparisons of behaviors pre- and post-injury/illness.

Technical information

Normative data are derived from a community-based sample of 436 men and women for two levels of education; data are also provided for several clinical groups, including patients with frontotemporal dementia, frontal lesions, nonfrontal stroke, head injury, Alzheimer’s disease, Huntington’s disease, and Parkinson’s disease.

Copyright ©  by PAR, Inc., privately owned and operated since 1978. All rights reserved (N).